Verrix to Exhibit at International Association of Healthcare Central Service Material Management 2019 Annual Conference

April 25, 2019 |

2 min read

Experts to Discuss the Future of Sterilization Monitoring Using Technology Developed by NASA’s Jet Propulsion Laboratory

April 25, 2019 12:22 UTC

WHEN:		Sunday, April 28, 2019, to Wednesday, May 1, 2019

WHAT:		Verrix will be exhibiting at the IAHCSMM 2019 Annual Conference & Expo to discuss critical needs in sterilization monitoring and engage with champions in the sterile processing field to explore the future of sterile processing.

WHY:		Inadequately sterilized surgical instruments are a major contributor to infection outbreaks. Biological indicator (BI) systems are used to monitor the lethality of sterilization cycles and detect failed cycles, providing greater confidence that surgical instruments are free from contamination. Delays and inaccuracies in the sterilization confirmation process can lead to unwarranted risk and operational disruption. Verrix is taking a new approach to develop solutions that deliver BI results with unprecedented speed and accuracy and eliminate common causes of error.

HIGHLIGHTS:
		Meet Adrian Ponce, Ph.D., Verrix Founder/Inventor and NASA Jet Propulsion Laboratory Scientist, on Monday, April 29, 1–5 p.m. PDT.
		Interview the Verrix team of scientists and commercial partners working to develop solutions for accurate and rapid sterilization confirmation.
		Verrix to hold drawing for conference attendees to win one of three $500 education vouchers (valid for use on accredited educational expenses).

WHERE:		Booth #821 at the Anaheim Marriott and Convention Center, 800 West Katella Ave., Anaheim, CA 92802.

About Verrix

Verrix is a San Clemente, Calif.-based medical device company that is using the most advanced technologies to help protect patients from healthcare-associated infections. The foundational sterility assurance technology, originally discovered at NASA’s Jet Propulsion Laboratory, integrates cutting-edge optical physics, chemistry spectroscopy, and molecular biology. Based on scientific expertise and close partnerships with healthcare professionals, Verrix is developing market-changing solutions for sterility assurance, environmental monitoring, and infection control. Visit www.verrix.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190425005095/en/

Contacts

Media Contacts
Andrea Sampson, Sullivan & Sampson PR
asampson@sullivanpr.com, 714/374-6174

Erin Manning, Vice President, Marketing, Verrix
erin.manning@verrix.com, 949/668-1229

Source: Verrix

View this news release online at:
http://www.businesswire.com/news/home/20190425005095/en

Events